Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

JNK signaling maintains the mesenchymal properties of multi-drug resistant human epidermoid carcinoma KB cells through snail and twist1

Contributed equally
BMC Cancer201313:180

https://doi.org/10.1186/1471-2407-13-180

Received: 10 December 2012

Accepted: 26 March 2013

Published: 4 April 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
10 Dec 2012 Submitted Original manuscript
12 Dec 2012 Author responded Author comments - Wenfu Tan
Resubmission - Version 2
12 Dec 2012 Submitted Manuscript version 2
22 Jan 2013 Reviewed Reviewer Report - Hiroshi Kajiya
1 Feb 2013 Reviewed Reviewer Report - Juan F. Santibanez
12 Mar 2013 Author responded Author comments - Wenfu Tan
Resubmission - Version 3
12 Mar 2013 Submitted Manuscript version 3
12 Mar 2013 Author responded Author comments - Wenfu Tan
Resubmission - Version 4
12 Mar 2013 Submitted Manuscript version 4
21 Mar 2013 Author responded Author comments - Wenfu Tan
Resubmission - Version 5
21 Mar 2013 Submitted Manuscript version 5
Publishing
26 Mar 2013 Editorially accepted
4 Apr 2013 Article published 10.1186/1471-2407-13-180

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Pharmacology, School of Pharmacy, Fudan University
(2)
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
(3)
Medical School of Nantong University
(4)
Department of Integration of Traditional Chinese and Western Medicine, Peking University School of Oncology, Beijing Cancer Hospital

Advertisement